Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Precancerous cells present, Reticulocyte count increased, Smear cervix abnormal
Clinical narrative: positive for antinuclear antibodies/abnormal bloodwork; thyroid receptor antibody positive/abnromal bloodwork; pap smears became abnormal; autonomic, and neurological, injuries; abnormal uterine bleeding; autonomic, and neurological, injuries; autoimmune hemolytic anemia/extreme fatigue/chest pain/chronic headaches/high retikulocyte count; received the second Gardasil vaccination on December 30, 2020; precancerous cells were found during her routine pap smear; Information has been received from a lawyer, regarding a case in litigation and an adult female patient (pt). Prior to receiving the suspect vaccine, she was happy and healthy and working full time. No other information concerning the pt's medical history, concurrent conditions or concomitant medications was provided.  On 15-JAN-2020, at the age of 23 years old, the pt received his first dose of quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for preventing cervical cancer. Shortly after the administration of the vaccine, the pt started having an adverse reaction to the quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination requiring her to see many doctors and visit the emergency work. As the months progressed, so did the pt's injuries. She was seen by multiple physicians and specialists for her complaints. On an unknown date, the pt experienced abnormal bloodwork, abnormal uterine bleeding, chest pain, chronic headaches, and extreme fatigue. On an unknown date, following the quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations (discrepant information), the pt's pap smears became abnormal. On 30-DEC-2020, the pt received his second dose of quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiration date were not reported) (inappropriate schedule of vaccine administered). On an unspecified date in 2022, precancerous cells were found during the pt's routine pap smear. As a result of his post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was unable to engage in activities that a normal young person would enjoy. Since receiving quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the pt was unable to work more than 25 hours a week due to her injuries. Her symptoms also substantially interfered with her personal life. On unknown dates, based upon his chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was diagnosed with various medical conditions, including but not limited to, autoimmune hemolytic anemia. The pt was also positive for antinuclear antibodies, had a high reticulocyte count, and was thyroid receptor antibody positive. The pt contended that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection(s) caused her to develop serious and debilitating autoimmune, autonomic, and neurological injuries and resulting sequalae, including but not limited to autoimmune hemolytic anemia, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. The pt had suffered and at the time of report continued to suffer severe and permanent physical injuries, and associated symptomatology and had suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with his autoimmune disease and other injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt suffered and at the time of report continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future.  The outcome of the events of autoimmune haemolytic anaemia, antinuclear antibody positive, anti-thyroid antibody positive, papanicolaou smear abnormal, precancerous cells present, abnormal uterine bleeding, unspecified disorder of autonomic nervous system and neurological disorder were considered to be not recovered. The lawyer considered the events of autoimmune haemolytic anaemia, antinuclear antibody positive, anti-thyroid antibody positive, papanicolaou smear abnormal, precancerous cells present, unspecified disorder of autonomic nervous system and and neurological disorder to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  Upon internal review, the event of autoimmune haemolytic anaemia was determined to be medically significant. The events of autoimmune haemolytic anaemia, antinuclear antibody positive, anti-thyroid antibody positive, papanicolaou smear abnormal, precancerous cells present, abnormal uterine bleeding, unspecified disorder of autonomic nervous system and and neurological disorder were considered to be disabling.